FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program 
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling 
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties 
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland 
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year 
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown 
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants 
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement 
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project 
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift 
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group 
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy 
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions 
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study 
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role 
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement 
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip 
NEW YORK, March 23, 2016 -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of Santander Consumer USA Holdings Inc. (“Santander” or the “Company”) (NYSE:SC) between February 3, 2015 and March 15, 2016.
You are hereby notified that a securities class action has commenced in the USDC for the Northern District of Texas. If you purchased or otherwise acquired Santander securities between February 3, 2015 and March 15, 2016, your rights may be affected by this action. To get more information go to: http://www.zlk.com/pslra/santander-consumer-usa-holdings-inc.
The complaint alleges that defendants violated the Securities Exchange Act of 1934 by failing to disclose during the Class Period that the Company’s methodology for estimating credit loss allowance on individually acquired retail installment contracts was improper and would require correction of previously issued financial statements.
On February 29, 2016, Santander disclosed it was unable to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2015. On March 15, 2016, Santander disclosed it would not meet the extended filing deadline for its 2015 Annual Report, citing an inability to implement changes to its methodology for estimating credit loss allowance on individually acquired retail installment contracts to address concerns raised by the Division of Corporation Finance of the SEC.
If you suffered a loss in Santander you have until May 17, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://www.zlk.com/pslra/santander-consumer-usa-holdings-inc.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive experience representing investors in securities litigation involving financial fraud, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLP Eduard Korsinsky, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com
